What can you expect from this site?

You can find essential files and documents to assess and investigate various topics, providing investors with everything needed to decide on proceeding with deeper conversations and supporting due diligence.

Topics:

 1, Company Overview
2, Ensynox Nanotechnology intro
3, Approaches to investors to consider
4, Strategic Plan
5, Pitch Deck (Full version)
6, Investment opportunity with us in Brazil
7, Visionary statement - industry specifications
8, Strategic buyer and collaborator connections - upon request
9, Financial Plan (Excel) - upon request
10, Investment breakdown - use of funds - upon request
11, Road-to-IPO (4-year plan) - upon request (Excel)
12, Ensynox Brochure 2026 (Environmental and agricultural)

We invite investor inquiries and are pleased to provide answers.
Contact name: Attila Tottosi
Position: CEO/Founder
Tel.: +1-941-718-3373  or  +1-877-ENSYNOX (+1-877-367-9669)
Email: attila.tottosi@ensynox.com

Company Overview (PDF)

This document offers an overview of our company, detailing our business operations, milestones, current projects, clients, and future revenue sources. Most importantly, we deliver IIMPACT on business, human, and planetary health. We combine our passion with scientific knowledge, industry expertise, and an entrepreneurial spirit to deliver profitable results that benefit human health and environmental sustainability, and enhance climate resilience. Our guiding principles are: People - Planet - Profit.
Click on the "Read in full" button below to get the full document.

Approaches for Investor (PDF)

Proven de-risking, FOMO, turnaround/cash-flow, and many more valuable pieces of information to assess.
Click on the "Read in full" button below to get the full document.

Pitch Deck (full) (PDF)

This is a full-deck version with details.

We are visionary entrepreneurs seeking to connect with investors who share a similar outlook and attitude and understand our mission. Together, we can make a significant impact on business revenue, as well as human, environmental, and planetary health. We are not philanthropists who simply donate their wealth.
Our mission is to create positive impacts on human, environmental, and planetary health, enhance climate resilience, and contribute to a sustainable future. We offer comprehensive solutions that promote coexistence between humanity and nature. This is where we excel and generate profit across multiple industries.
Our primary focus is to educate, take action, and foster meaningful change. We are leading by example and shaping the future today.
At the same time, we are focused on building strong brands, a lasting legacy, and a solid reputation. The value of our company and our technology is well established. Whether we are discussing a $3.5 million valuation for the company or a $475 million valuation for the technologies, what truly matters is our growth direction and speed. Let’s use this as a starting point.

The best way to assess the potential is to ask questions. These are poetic questions; we know the answers, but it would be great if our visionary investor considered them and reached the same conclusion.

The main questions:
1. What will be the worth of our company and our technologies in a few years, especially at the pre-IPO and IPO?
2. How much revenue and profit can we achieve in multiple industries if we have the best proven effective solution to significant problems and the competition cannot fill the gaps, and there is strong demand to address these issues?

We have those answers, and we can defend our statements with proof, scientific and industry data, market trends, and statistics.
Let me break it down in a few industries below: why our technologies will build dominance :

Agriculture is one of our primary industries.
Synthetic chemicals, fertilizers, pesticides, fungicides, and herbicides serve only as temporary solutions. While they may provide short-term benefits, they ultimately harm the soil’s microbiome, reduce its regenerative capacity, and deplete soil carbon, negatively impacting all forms of life. Furthermore, these chemicals can damage the environment and make the soil more acidic. Up to 80% of nitrogen and phosphorus from these substances can seep into groundwater. The overapplication of fertilizers and pesticides is dramatically increasing due to weather-related challenges. Since 2020, fertilizer costs have surged by 70%. Additionally, synthetic chemicals, especially pesticides, can enter the human body and disrupt endocrine and hormonal systems. Moreover, the nutritional value of agricultural produce has significantly declined, now only a fraction of what it was 20 to 30 years ago.

The total annual revenue from agriculture is as follows: - USA: approximately $611 billion. - In Brazil, agribusiness contributes 25% to the country's GDP and accounts for half of the total global agricultural exports. In 2024, Brazil surpassed the USA to become the number one agricultural exporter. This is why we prioritize the Brazilian and US markets, where our products have already gained significant attention.
Our organic enzyme liquid protein fertilizer improves soil quality, restores microbial balance, and increases soil carbon levels. Farmers benefit from reduced synthetic input costs while the environment can regenerate effectively.
We analyzed the agricultural market in Brazil and built a chain of connections.
We have successfully secured 5 hectares of land in an industrial park in Rio Grande do Norte, located in northern Brazil. Additionally, we have engaged in discussions in central Brazil (Mato Grosso) and southern Brazil (São Paulo), where several large companies are interested in testing our product and may place orders. In northern Brazil, we have established collaborations with numerous buyers who own between 7,000 and 10,000 hectares of land. Meanwhile, in São Paulo, some buyers represent large industrial companies with landholdings of up to 300,000 hectares.

Food industry

Processed and ultra-processed foods (UPF) represent a secondary industry for us, at least in terms of timing. In the USA, 65% of what people buy and consume consists of ultra-processed food, and the situation is not much better globally. In today's fast-paced world, proper nutrition often takes a backseat due to time constraints and higher costs. UPF simplifies eating and makes life easier while still providing pleasurable food. However, this convenience comes at a high price.
Through multiple processing steps, UPFs lose essential nutritional value, including vitamins, minerals, and trace elements. But the loss of nutrients is not the most concerning issue. UPFs often contain numerous unhealthy components, including food additives, dyes, synthetic chemicals, enhancers, emulsifiers, etc., which can be difficult for the body to process and may accumulate over time.
In many cases, these substances can lead to changes in the body, enzyme deficiencies, and inflammation, potentially resulting in disease. The human body contains approximately 75,000 different enzymes, and when one enzyme becomes impaired, it can trigger a cascade effect on others. This is a slow process, but it is a process.
Our product aims to address these issues. What would happen, and how would the market and consumers respond, if a product were introduced that embodied the idea behind the famous slogan, "Let your food be your healer"?
This is who we are. Our special food ingredient formula helps the body rid of harmful accumulated components, and buyers easily commit themselves to consuming products containing ExTRA.
Ex is a short trademarked form of Ensynox, TRA stands for Toxin-Removal-Agent.
Ex is organic and so harmless; the toxin removal capability is backed by scientific data. You can figure out the chance of success.
The contact and consultation have started with food scientists.
We can share confidential details.
As we mentioned, it is not a fast-paced project; there is still work that needs to be done, and the regulatory process for a food ingredient takes around 18 months.
But we will start the ball rolling.

Addressing environmental issues is one of our primary industries. We have extensive experience from pilot projects, laboratory tests, and field trials in various environments. These jobs are high-paying but can also be challenging to secure due to the politicized nature surrounding these projects. However, we have invested the necessary resources to learn how to successfully tackle these jobs and ultimately achieve our goals.
We offer both individual projects and contractual jobs that involve continuous maintenance for both public (government) and private sectors. Our services include algae cleanup, toxic soil remediation, bacteria removal, sewage sludge treatment, and oil sludge treatment, among others.
Recent scientific data demonstrates our enzyme's ability to neutralize heavy metals, which poses a significant concern for both the environment and the food industry.
Our enzyme effectively neutralized various heavy metals at a high rate within just 5 days, achieving a success rate of over 95-98% for contaminants such as arsenic, mercury, cobalt, cadmium, and molybdenum. It is effective regardless of the medium—whether in soil, sewage sludge, oil sludge, or water. Additionally, soil cleanup can be highly profitable in real estate, particularly when heavily polluted lands (often referred to as brownfields) are unable to secure building permits due to public health concerns.

Biomedicine

This is an industry where we will not directly establish a business. We are all aware of the issues surrounding big pharma, and it's best to steer clear of that. However, since Ensynox has a uniquely formulated anti-inflammatory solution supported by numerous medical studies, we believe it is our responsibility to offer the peak version of this product to humanity, of course, on a commercial basis.
We will approach this strategically. We plan to partner with medical research and pharmaceutical companies and license them to work with Ensynox on focused medical research and the development of biomedical solutions for diseases, vaccines, and more. In exchange for their research efforts, we will utilize their findings related to harmful components in our communications about the food ingredient product. Contacts and discussions have already been made.
I understand that there may be concerns and doubts regarding the capabilities of our biomedical technology. To help alleviate those concerns and build your confidence, the website provided at the bottom offers extensive information on how earthworm extracts can make a significant impact. The medical field is aware of this potential and has conducted substantial research; however, it lacks the industrial and manufacturing expertise that we possess. On the website, you will find numerous human trials and scientific studies that demonstrate the effectiveness of earthworms in addressing serious health issues, including various cancer-related conditions.
This proven healing and anti-inflammatory capability is a key aspect. This is why our product is effective in multiple industries: it promotes regeneration, which is the essence and result of our enzyme, and it is needed in many industries.
https://www.ensynox.com/ensynox-as-biomedicine

While it is not our top priority, I would like to highlight our ocean-related initiative, The Poseidon Projects (www.theposeidonprojects.com).
Originally established as a non-profit under a fiscal sponsorship with a Maryland Trust, we have a solid plan to transform it into a profitable business through special projects. One of our patents is specifically designed to address challenges in saltwater environments and has received positive evaluations at the federal level. We have also secured green lights for grants from the National Science Foundation, and our academic partner is one of the world's leading oceanography institutions. We will begin the development of these projects as we continue to grow.

4-year plan

Our long-term plan includes preparing for a targeted pre-IPO and IPO between the 3rd and 4th years. In the third year, as we get ready for the pre-IPO, targeting institutional investors, venture capitalists, family offices, and selected investors, we will ensure our portfolio is completely open and transparent. The public will have full insight into our operations, our identity, and the impact of our activities.
All the projects and brands we communicate about across various industries are part of a sustainable system aimed at making the world a better and safer place.
Our Road-to-IPO guidelines outline the steps we take to build our empire and achieve success.
There is no better investment than in stocks focused on human and environmental health, sustainability, biodiversity, and climate health.
It is the future of our children and the generations to come.
This movement is forever green, and we act as both a compass and a lighthouse, guiding the way forward.